Literature DB >> 2479471

Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid.

N G Tanaka1, N Sakamoto, K Inoue, H Korenaga, S Kadoya, H Ogawa, Y Osada.   

Abstract

A sulfated polysaccharide-peptidoglycan complex, DS-4152, isolated from the culture supernatant of an Arthrobacter species inhibited angiogenesis and tumor growth and enhanced the antiangiogenic activity of 11 steroid hormones by 2 to 100 times. In the presence of cortisone acetate or tetrahydro S, DS-4152 suppressed chick chorioallantoic membrane angiogenesis and murine tumor M5076 cell-induced s.c. angiogenesis. The antitumor effects of DS-4152 administered in combination with a steroid whose dose level did not affect tumor growth were examined. DS-4152 significantly inhibited the growth of s.c.-implanted B16 melanoma in combination with cortisone acetate. DS-4152 plus tetrahydro S inhibited the growth of s.c. solid tumors and prolonged the survival time of mice bearing highly metastasizing M5076. The body weight increase was not affected by any administration. On the other hand, the survival of mice with ascitic M5076 tumors was not affected by the combination of DS-4152 plus tetrahydro S. The antiangiogenic activity of DS-4152 was more potent than that of heparin. Furthermore, DS-4152 is an angiogenesis inhibitor by itself, without steroid hormones. Successive s.c. treatment with heparin caused hemorrhagic death, but with DS-4152, suppressed tumor growth without reducing body weight.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479471

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.

Authors:  M Thornton; L Barkley; J C Mason; S Shaunak
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression.

Authors:  M Aonuma; Y Saeki; T Akimoto; Y Nakayama; C Hattori; Y Yoshitake; K Nishikawa; M Shibuya; N G Tanaka
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

3.  Effects of group B Streptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors.

Authors:  G B Thurman; B A Russel; G E York; Y F Wang; D L Page; H W Sundell; C G Hellerqvist
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus.

Authors:  C G Hellerqvist; G B Thurman; D L Page; Y F Wang; B A Russell; C A Montgomery; H W Sundell
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 5.  The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-08

6.  Inhibition of angiogenesis by rhizoxin, a microbial metabolite containing two epoxide groups.

Authors:  C Onozawa; M Shimamura; S Iwasaki; T Oikawa
Journal:  Jpn J Cancer Res       Date:  1997-12

7.  Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice.

Authors:  P J Browning; D D Roberts; V Zabrenetzky; J Bryant; M Kaplan; R H Washington; A Panet; R C Gallo; T Vogel
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

8.  Inhibition of angiogenesis and murine tumour growth by laminarin sulphate.

Authors:  R Hoffman; D H Paper; J Donaldson; H Vogl
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.